Taysha Gene Therapies Inc. Made Big Gain

Tue, Nov 12, 2024 at 07:33 PM

Taysha Gene Therapies Inc. (TSHA:NASDAQ) jumped higher at $2.39, a gain of 46.6%. On Tue, Nov 12, 2024, TSHA:NASDAQ touched a New 2-Week High of $2.39. The stock appeared on our News Catalysts scanner on Thu, Nov 07, 2024 at 09:30 PM in the 'INVESTOR UPDATE' category. From Tue, Oct 29, 2024, the stock recorded 50.00% Up Days and 45.45% Green Days

The stock spiked on Thu, Jun 13, 2024 at $4.32 with a volume of 2M+.

About Taysha Gene Therapies Inc. (TSHA:NASDAQ)

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease.

Top 10 Gainers:

BTC Digital Ltd. (BTCT:NASDAQ), 316.67%
Nano Labs Ltd (NA:NASDAQ), 134.04%
Next Technology Holding Inc. (NXTT:NASDAQ), 76.52%
Mullen Automotive Inc. (MULN:NASDAQ), 74.27%
Genius Group Limited (GNS:NYSEMKT), 66.4%
Agrify Corporation (AGFY:NASDAQ), 58.59%
Genprex, Inc. (GNPX:NASDAQ), 55.97%
Kairos Pharma Ltd. (KAPA:NYSEMKT), 51.05%
MediciNova, Inc. (MNOV:NASDAQ), 49.02%
Taysha Gene Therapies Inc. (TSHA:NASDAQ), 46.63%